6 January 2022 - Today, the Centers for Medicare & Medicaid Services issued a proposed rule that would make updates to the Medicare Advantage and Medicare Part D programs that would lower out of pocket prescription drug costs for beneficiaries with Medicare Part D and improve price transparency and market competition.
The proposed rule would improve beneficiaries’ experiences with Medicare Advantage and Part D, with a strong emphasis on individuals who are dually eligible for Medicare and Medicaid. Ultimately, CMS is taking action to hold Medicare Advantage and Part D plans to a higher standard in offering benefits and improve health equity in the programs.